Fulgent Genetics (FLGT) Invested Capital (2020 - 2023)

Fulgent Genetics has reported Invested Capital for 4 years, with the latest figure at $15.0 million in Q1 2023.

• Quarterly Invested Capital changed 0.01% year-over-year to $15.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $15.0 million (down 75.0% YoY) and the FY2022 annual result came in at $15.0 million, down 0.91% from the prior year.
• Invested Capital was little changed at $15.0 million in Q1 2023 per FLGT's latest filing, from $15.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $15.1 million in Q4 2021 and troughed at $15.0 million in Q4 2022.
• A 4-year average of $15.0 million and a median of $15.0 million in 2020 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2021 and 2022: Invested Capital grew 0.79% in 2021, then decreased 0.91% in 2022.
• Over 4 years, Invested Capital stood at $15.0 million in 2020, then rose by 0.79% to $15.1 million in 2021, then declined by 0.91% to $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023.
• According to Business Quant data, Invested Capital over the past three periods registered $15.0 million, $15.0 million, and $15.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.